Status: current, Defined. Date: 31-Oct 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2800781000168115 | Lymph-Flo Antimony Trisulfide (antimony trisulfide 1.1 mg / 1 mL) injection, 1 x 1 mL vial (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2800791000168117 | Lymph-Flo Antimony Trisulfide 1.1 mg/mL injection, 1 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lymph-Flo Antimony Trisulfide 1.1 mg/mL injection, 1 mL vial | Is a | Lymph-Flo Antimony Trisulfide 1.1 mg/mL injection, 1 mL vial | true | Inferred relationship | Some | ||
| Lymph-Flo Antimony Trisulfide 1.1 mg/mL injection, 1 mL vial | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Lymph-Flo Antimony Trisulfide 1.1 mg/mL injection, 1 mL vial | has TPUU | Lymph-Flo Antimony Trisulfide 1.1 mg/mL injection, vial | true | Inferred relationship | Some | 1 | |
| Lymph-Flo Antimony Trisulfide 1.1 mg/mL injection, 1 mL vial | has container type | vial | true | Inferred relationship | Some | ||
| Lymph-Flo Antimony Trisulfide 1.1 mg/mL injection, 1 mL vial | has TP | Lymph-Flo Antimony Trisulfide | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lymph-Flo (1 x Antimony Trisulfide vial, 1 x Phosphate Buffer vial, 1 x Hydrochloric Acid vial), 1 pack | has component pack | True | Lymph-Flo Antimony Trisulfide 1.1 mg/mL injection, 1 mL vial | Inferred relationship | Some |
Reference Sets
Containered trade product pack reference set
FHIR